✦ LIBER ✦

Trazodone label now warns of potential interactions via CYP3A4

Book ID: 120856364
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414380-00057

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A clinical study investigating the pharm

A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate

✍ Milan Zdravkovic; Anette K. Olsen; Tina Christiansen; Rainer Schulz; Mitchell E. 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 236 KB

Fluorescent Probes for Rapid Screening o

Fluorescent Probes for Rapid Screening of Potential Drug–Drug Interactions at the CYP3A4 Level

✍ Antoinette Chougnet; Yelena Grinkova; David Ricard; Stephen Sligar; Wolf-D. Wogg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 1 views

Time-dependent inhibition (TDI) of CYP3A

Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine–warfarin interaction

✍ Zhong-Ze Fang; Yan-Yan Zhang; Guang-Bo Ge; Hong Huo; Si-Cheng Liang; Ling Yang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Molecular docking to understand the meta

Molecular docking to understand the metabolic behavior of GNF-351 by CYP3A4 and its potential drug–drug interaction with ketoconazole

✍ Liu, Tao; Qian, Ge; Wang, WenTing; Zhang, YanGuo 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 364 KB

Dual drug interactions via P-glycoprotei

Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamil

✍ Nuggehally R. Srinivas 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 58 KB